Gibson Dunn Advises Concentra Biosciences on Acquisition of iTeos Therapeutics, Inc.
Dan Mulloy
Gibson Dunn is representing Concentra Biosciences, an affiliate of Tang Capital Management, on its acquisition of iTeos Therapeutics, Inc. (Nasdaq: … The post Gibson Dunn Advises Concentra Biosciences on Acquisition of iTeos Therapeutics, Inc. appeared first on Gibson Dunn .